Reuters
HONG KONG/BEIJING (Reuters) -Hong Kong-listed shares of China's WuXi AppTec jumped as much as 9.8% on Monday after it said it has no links with any governments or their military organisations, and it should not be listed as a "biotechnology company of concern" in a draft U.S. bill. The drug research and development group said in a filing to the Shanghai Stock Exchange on Sunday that it has no human genomics business and does not collect human genome data in any of its existing businesses. A U.S. congressional committee focused on China has introduced a bill that would restrict federally funded medical providers from contracting WuXi AppTec and other Chinese biotech companies, citing WuXi AppTec's alleged military ties as part of the reason.